Pricing Log in Create free account

Cumberland Pharmaceuticals Inc. (CPIX) vs Zhengye Biotechnology Holding Limited (ZYBT)

Cumberland Pharmaceuticals Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. Cumberland Pharmaceuticals Inc. is the larger, with a market value of $75.1M against $41.0M — 1.8× the size. Across the 9 metrics below, Cumberland Pharmaceuticals Inc. leads on 5 and Zhengye Biotechnology Holding Limited on 4.

Valuation

Metric CPIX ZYBT Drug Manufacturers Specialty & Generic median
P/E n/m — 20.55
P/S 2.41 — 2.08
P/B 4.41 n/m 1.79
Price to free cash flow 131.12 n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 2.62 n/m 2.87
Earnings yield (14.48%) — (15.94%)
Free cash flow yield 0.76% 0.00% 0.00%

Profitability

Metric CPIX ZYBT Drug Manufacturers Specialty & Generic median
Gross margin 110.49% — 53.51%
Operating margin (23.20%) — 0.00%
Net margin (34.92%) — (2.45%)
Free cash flow margin 1.84% 0.00% 0.00%
Return on equity (48.76%) 0.00% (0.80%)
Return on assets (16.70%) 0.00% (1.67%)
Return on invested capital (34.23%) 0.00% 0.00%

Growth

Metric CPIX ZYBT Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (25.68%) — 5.22%
EPS growth (last fiscal year) 58.70% (800.00%) 42.91%
Revenue growth, 5-year CAGR 3.52% — 7.24%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CPIX ZYBT Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.24 0.04
Current ratio 0.96 1.14 2.41
Net debt to EBITDA (4.58) (0.51) 1.01

Dividend

Metric CPIX ZYBT Drug Manufacturers Specialty & Generic median
Dividend yield 0.00% — 1.45%
Payout ratio — — 0.27

Size

Metric CPIX ZYBT Drug Manufacturers Specialty & Generic median
Market cap 75.06m 41.02m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack